Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1633 1634 1635 1636 1643 1656
This examiner grants 60% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17413297 | ANELLOSOMES FOR DELIVERING PROTEIN REPLACEMENT THERAPEUTIC MODALITIES | Final Rejection | FLAGSHIP PIONEERING INNOVATIONS V, INC. |
| 17917358 | COMPOSITIONS AND METHODS FOR TREATING METABOLIC AND CARDIOVASCULAR DISEASES | Non-Final OA | UNIVERSITY OF ROCHESTER |
| 18763490 | METHODS AND COMPOSITIONS FOR MODIFYING A TARGETED LOCUS | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 17788519 | IMMUNOTHERAPY FOR DIRECT REPROGRAMMING OF CANCER CELLS INTO IMMUNE CELLS/ANTIGEN PRESENTING CELLS/DENDRITIC CELLS | Non-Final OA | University of Florida Research Foundation, Incorporated |
| 18279169 | PRODUCTS AND METHODS FOR TREATMENT OF DYSTROPHIN-BASED MYOPATHIES USING CRISPR-CAS9 TO CORRECT DMD EXON DUPLICATIONS | Non-Final OA | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL |
| 18038878 | COMPOSITIONS AND METHODS FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY (FSHD) | Non-Final OA | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL |
| 17842891 | HAIRPIN STRUCTURE NUCLEIC ACID MOLECULES CAPABLE OF MODULATING TARGET GENE EXPRESSION AND USES THEREOF | Final Rejection | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 17628361 | CHIMERIC MOLECULE, PHARMACEUTICAL COMPOSITION, METHOD FOR CLEAVING TARGET NUCLEIC ACID, AND KIT FOR TARGET NUCLEIC ACID CLEAVAGE OR DIAGNOSIS | Final Rejection | TOHOKU UNIVERSITY |
| 18420013 | METHOD FOR DIAGNOSING DRUG ADDICTION, METHOD FOR SCREENING THERAPEUTIC AGENT FOR DRUG ADDICTION AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DRUG ADDICTION | Final Rejection | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 18036677 | LNP COMPOSITIONS COMPRISING RNA AND METHODS FOR PREPARING, STORING AND USING THE SAME | Non-Final OA | BioNTech SE |
| 17311271 | MODIFIED PROTEINS AND ASSOCIATED METHODS OF TREATMENT | Final Rejection | Arcturus Therapeutics, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy